Wuhan Easy Diagnosis Biomedicine Co Ltd Class A Financial Flexibility Index
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A financial flexibility index. Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) has a Financial Flexibility Index of 0.07x as of September 2025. Free cash flow of CN¥24.82 Million (operating CF CN¥15.57 Million minus capex CN¥9.26 Million) represents 0% of total liabilities (CN¥373.70 Million). Explore Wuhan Easy Diagnosis Biomedicine Co Ltd (002932) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (2011–2025)
Financial flexibility index of Wuhan Easy Diagnosis Biomedicine Co Ltd Class A from 2011 to 2025. Historical Financial Flexibility Index trend for Wuhan Easy Diagnosis Biomedicine Co Ltd Class A across 15 annual periods. Check cash flow reinvestment rate of Wuhan Easy Diagnosis Biomedicine Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A Financial Flexibility Index by Year (2011–2025)
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A financial flexibility index by year from 2011 to 2025. Year-by-year free cash flow to debt coverage for Wuhan Easy Diagnosis Biomedicine Co Ltd Class A. For the full cash flow conversion analysis, see cash flow conversion of Wuhan Easy Diagnosis Biomedicine Co Ltd .
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.06x | CN¥20.84 Million | CN¥-70.05 Million | CN¥324.56 Million | ▼ -63.0% |
| 2024 | 0.17x | CN¥99.72 Million | CN¥-85.05 Million | CN¥574.40 Million | ▼ -62.2% |
| 2023 | 0.46x | CN¥502.47 Million | CN¥392.50 Million | CN¥1.09 Billion | ▼ -74.3% |
| 2022 | 1.79x | CN¥4.33 Billion | CN¥4.01 Billion | CN¥2.42 Billion | ▼ -17.6% |
| 2021 | 2.17x | CN¥1.23 Billion | CN¥1.13 Billion | CN¥567.02 Million | ▲ +74.4% |
| 2020 | 1.24x | CN¥387.97 Million | CN¥359.68 Million | CN¥311.77 Million | ▼ -47.9% |
| 2019 | 2.39x | CN¥54.42 Million | CN¥22.49 Million | CN¥22.80 Million | ▼ -42.1% |
| 2018 | 4.12x | CN¥101.15 Million | CN¥53.67 Million | CN¥24.55 Million | ▼ -39.1% |
| 2017 | 6.76x | CN¥92.01 Million | CN¥46.50 Million | CN¥13.60 Million | ▲ +50.6% |
| 2016 | 4.49x | CN¥99.13 Million | CN¥58.86 Million | CN¥22.07 Million | ▲ +80.5% |
| 2015 | 2.49x | CN¥46.20 Million | CN¥45.02 Million | CN¥18.57 Million | ▲ +37.2% |
| 2014 | 1.81x | CN¥20.71 Million | CN¥16.47 Million | CN¥11.42 Million | ▲ +104.7% |
| 2013 | 0.89x | CN¥9.03 Million | CN¥6.30 Million | CN¥10.19 Million | ▲ +77.3% |
| 2012 | 0.50x | CN¥1.62 Million | CN¥1.03 Million | CN¥3.23 Million | ▲ +369.2% |
| 2011 | -0.19x | CN¥-359.32K | CN¥-482.90K | CN¥1.94 Million | — |